ABSTRACT
Our aim was to determine whether a single transplatin monofunctional adduct,
either
trans
-[Pt(NH
3
)
2
(dC)Cl]
+
or
trans
-[Pt(NH
3
)
2
(dG)Cl]
+
within a homopyrimidine oligonucleotide, could further react and form an
interstrand cross-link once the platinated oligonucleotide was bound to the complementary
duplex. The single monofunctional adduct was located at either the 5
'
end or in the middle of the platinated oligonucleotide. In all the triplexes,
specific interstrand cross-links were formed between the platinated Hoogsteen strand and the
complementary purine-rich strand. No interstrand cross-links were detected between the platinated oligonucleotides and non-complementary DNA. The yield and the rate of the cross-linking reaction depend upon the nature and location of
the monofunctional adducts. Half-lives of the monofunctional adducts within the triplexes were in the range
2-6 h. The potential use of the platinated oligonucleotides to modulate
gene expression is discussed.
During recent years, much work has been devoted to the study of nucleic acids
triplexes. It has been demonstrated that homopyrimidine oligonucleotides can be
targeted to homopurine-homopyrimidine tracts of DNA. The oligonucleotides bind to the major
groove of DNA, forming a triple helix. Sequence specificity is achieved by
Hoogsteen hydrogen bonding interaction of thymine with A[middot]T and protonated cytosine with G[middot]C base pairs, respectively. These results and others concerning
homopurine oligonucleotides, mixed oligonucleotides and modified
oligonucleotides have opened a new field of investigation (the so-called anti-gene strategy), largely aimed at the design of sequence-specific gene modulators (
1
-
6
and references therein).
The formation of a local triple helix can affect gene expression in several ways
(
1
-
6
). However, a major problem in
in vitro
and
in vivo
experiments arises from the stability of the triplexes. Even if the triplexes
are stable under physiological conditions, they can be displaced by the
replication or the transcription machinery (
1
-
6
). One possibility to avoid this displacement is to cross-link the third strand to the duplex. This has been achieved by attaching
covalently to the oligonucleotides reagents able to react spontaneously or
after light activation with the duplexes (
2
). Among the chemical reagents, platinum(II) derivatives have been already used
in duplexes (
7
-
8
). Gruff and Orgel (
9
) demonstrated that binuclear platinum(II) complexes of the form [{
trans
-Pt(NH
3
)
2
Cl}
2
{NH
2
(CH
2
)
n
}]Cl
2
react rapidly with oligodeoxynucleotide-5'-phosphorothioates and then with polypurine tracts in triple
helical DNA.
Our aim was to determine whether the bifunctional compound
trans
-diamminedichloroplatinum(II) (transplatin) could be used as a cross-linking reagent in triplexes. Recent results on nucleobases have
shown that replacement of a weakly acidic N-H proton in a hydrogen bond between two nucleobases by a metal species of
suitable geometry generates metal-modified nucleobase pairs (
10
-
12
). The linkage between the two nucleobase pairs becomes considerably stronger as
hydrogen bonds are replaced by covalent bonds. In the case of G[middot]C Hoogsteen pairing and transplatin, the platinated pair fits almost
exactly the requirement of normal DNA as far as interglycosyl distances are
concerned. These results suggested that a monofunctional adduct
trans
-[Pt(NH
3
)
2
(dC)Cl]
+
within the Hoogsteen strand of a triplex is in an ideal position to cross-link the complementary purine-rich strand. They also suggested that the platinated C residue can
be replaced by a platinated G residue but the cross-linking reaction requires a switch from the anti to the syn conformation
for the platinated G residue. In this paper, we have studied the cross-linking reaction between homopyrimidine oligonucleotides containing a
single transplatin monofunctional adduct (
trans
-[Pt(NH
3
)
2
(dC)Cl]
+
or
trans
-[Pt(NH
3
)
2
(dG)Cl]
+
) and the complementary duplex. We show that specific interstrand cross-links are formed. The rate and the yield of the cross-linking reaction depend upon the nature and location of the
monofunctional adduct residue within the Hoogsteen strand.
The oligodeoxyribonucleotides, purchased from Institut Pasteur (Paris) were
purified by ion-exchange chromatography on a Pharmacia FPLC system (
13
). Their sequences are given in Figure
1
. Endonucleases, alkaline phosphatase and T4 DNA ligase were from Biolabs or
Boehringer Mannheim, transplatin was from Johnson Matthey, electrophoresis-grade acrylamide and the other chemicals from Merck. The radioactive
products were from Amersham. The plasmid pLYR was constructed by insertion of
the duplex (d(GTCAGAAAAAGAAAGAAAAGAAACG).d(CGTTTCTTTTCTTTCTTTTTCTGAC)) into
Sma
I restriction site of plasmid pSP73 by standard procedures and then transformed
in
Escherichia coli
HB101. The cloning was confirmed by DNA sequencing.
Several single-stranded oligonucleotides (19mer) (see Fig.
1
for their sequences) were reacted with transplatin in conditions that the
platinated oligonucleotides contained a single monofunctional adduct, either
trans
-[Pt(NH
3
)
2
(dC)Cl]
+
or
trans
- [Pt(NH
3
)
2
(dG)Cl]
+
. After addition of the platinated oligonucleotides to the complementary duplex
(25 bp), the stability of the triplexes, the cross-linking reaction and the nature of the interstrand cross-links were studied. The first part of the work deals with the
oligonucleotides containing a single monofunctional
trans-
[Pt(NH
3
)
2
(dG)Cl]
+
adduct and the second part with the oligonucleotides containing a single
monofunctional
trans-
[Pt(NH
3
)
2
(dC)Cl]
+
adduct.
Stability of the triplexes
. The first step was to determine whether the presence of the monofunctional
adducts within the Hoogsteen strand prevented the formation of the triplexes.
The double helix (25 bp) and the homopyrimidine oligonucleotides (19mer)
containing or omitting a single monofunctional
trans-
[Pt(NH
3
)
2
(dG)Cl]
+
adduct were mixed, incubated in 150 mM NaClO
4
for 1 h at 4oC and then analysed by gel-retardation assays at 37oC and pH 5.5. As shown in Figure
2
, the triplex with platinated oligonucleotide I* (the platinated G is at the 5' end of the oligonucleotide) is stable whereas triplex with the
platinated oligonucleotide II* (the platinated G is at the seventh position
from the 5' end) is partially dissociated. In the same experimental conditions but
at 20oC, free duplexes were not detected (not shown). As the pH was increased,
all the triplexes were partially dissociated and completely dissociated at pH 7
(not shown).
All the experiments just described were also done using oligonucleotide III* as
Hoogsteen strand, which contains a single monofunctional
trans-
[Pt(NH
3
)
2
(dC)Cl]
+
adduct.
The presence of the adduct destabilized the triplex. At 37oC and pH 5.5, the presence of two bands of equal intensities in the gel-retardation assays (not shown) indicated a partial dissociation of
the triplex. Nevertheless, the cross-linking reaction occurred during the incubation of the triplex (Fig.
6
, left). There are three slowly migrating bands which indicates that at least
three different interstrand cross-links are formed. The cross-linking reaction rapidly reaches a plateau, the [tau]
1/2
(monofunctional adduct within the triplex) being ~2 h. After 8 h incubation, addition of oligonucleotide III* to the mixture resulted in the formation of more interstrand cross-links. As discussed in the case of oligonucleotide II*, the low yield
of the cross-linking reaction is due, at least in part, to the dissociation of the
triplex and to the formation of intrastrand cross-links within free oligonucleotide III*.
Figure
After purification of the triplexes containing an interstrand cross-link, the location of the interstrand cross-links was probed by means of DMS. The reactivity of the G residues
within the purine-rich strand is largely decreased as compared with the same G residues
within the duplex (Fig.
7
). This suggests that whatever the position of the monofunctional adduct in the
oligonucleotide, it further reacts to form interstrand cross-links within the triplex. It was not attempted to compare the reactivity
of the C residues in the two steps of the reaction (formation of monofunctional
adducts, formation of interstrand cross-links). However, to make sure that the C residue at the 5' end of oligonucleotide III did not play a major role, the
experiment was repeated with an 18mer which had the same sequence as the 19mer
III but no C residue at the 5' end. The results (not shown) confirmed the formation of interstrand
cross-links at the three sites.
Figure
Finally, the specificity of the cross-linking reaction was proved by comparing the binding of oligonucleotide
III* to pSP73 DNA with and without the insert. Interstrand cross-links were only formed with DNA containing the insert.
The purpose of this work was to study in triplexes the cross-linking reaction between a Watson-Crick duplex and its complementary Hoogsteen homopyrimidine strand which contained a single transplatin-monofunctional adduct.
The Hoogsteen strand was either the 19mer d(CT
5
CT
3
CT
4
CT
3
) or the same oligonucleotide in which one C residue (C1 or C7) was replaced by
one G residue. The reaction with transplatin was carried out where there was a
single monofunctional adduct per oligonucleotide (
trans-
[Pt(NH
3
)
2
(dC)Cl]
+
at one of the 4 positions 1, 7, 11 or 16,
trans-
[Pt(NH
3
)
2
(dG)Cl]
+
at position 1 or 7, respectively). In the case of oligonucleotides I and II
which contain only one G residue, the platination was done at acidic pH (below
the pK of C residues) which prevented reaction with the C residues (
19
,
21
). In the case of oligonucleotide III which contain several C residues (but no G
residues), all the C residues appeared to react with transplatin. Ion-exchange chromatography allows separation of oligonucleotides bearing one
adduct from those bearing several adducts but does not allow separation of
oligonucleotides III* modified at one of the four C residues. It is not yet
possible to platinate only one C or G residue within an oligonucleotide
containing several C or G residues. This should no longer be a problem since
two very recent and independent reports (
23
,
24
) have shown that site-specifically platinated oligonucleotides can be prepared by using
automated solid-phase synthesis.
The platinated oligonucleotides are able to bind to the complementary duplex and
form interstrand cross-links. The reaction is specific in the sense that no interstrand cross-links were formed with DNA which did not contain the complementary
duplex. The platination of the oligonucleotides does not interfere with a
parallel orientation of the Hoogsteen strand with respect to the purine-rich strand as shown by the location of the interstrand cross-links. The interstrand cross-links are only formed with the residues within the purine-rich strand, these residues being almost exclusively G
residues. A systematic study has still to be done but it is likely that the
cross-linking reaction could occur with an A residue if the G[middot]C base pair complementary to the monofunctional adduct were
replaced by a A[middot]T base pair. The interstrand cross-links stabilize the triplexes as shown by the protection of the G
residues within the purine-rich strand to DMS at pH 7 (in the same experimental conditions, the
unplatinated Hoogsteen strand does not bind to the duplex).
The cross-linking reaction is the fastest with the strand containing the monofunctional adduct
trans-
[Pt(NH
3
)
2
(dC)Cl]
+
([tau]
1/2
~2 h). However, the apparent yield of interstrand cross-links is only ~35%. Two reasons can explain this low yield. One is that the
monofunctional adduct, which prevents the formation of an hydrogen bond,
destabilizes the triplex (in our experimental conditions, half-triplex was dissociated). The other reason is a suicide reaction which
occurs simultaneously with the cross-linking reaction. This reaction concerns the closure of the monofunctional
adduct into intrastrand cross-link within the free platinated Hoogsteen oligonucleotide ([tau]
1/2
(
trans-
[Pt(NH
3
)
2
(dC)Cl]
+
) ~5 h). The consequence is a decrease of the concentration of this free
oligonucleotide and thus a possible dissociation of the Hoogsteen strand from
the triplex.
The highest yield of the cross-linking reaction is obtained with the monofunctional
trans-
[Pt(NH
3
)
2
(dG)Cl]
+
adduct at the 5' end of the Hoogsteen strand (oligonucleotide I*) and the lowest with the
same adduct in the middle of the strand (oligonucleotide II*). As discussed,
the yield depends upon the stability of the complexes and the competitive
suicide reaction of the monofunctional adducts. To a first approximation, the
rates of the suicide reactions within the free platinated single-stranded oligonucleotides (I*, II* and III*) are independent of the nature and location of the
monofunctional adduct. In our experimental conditions, the triplex with oligonucleotide I* is stable. The rate of the interstrand cross-linking reaction ([tau]
1/2
~6 h) is three-fold slower than that with
trans-
[Pt(NH
3
)
2
(dC)Cl]
+
. It means that the anti-syn rotation of
trans-
[Pt(NH
3
)
2
(dG)Cl]
+
required for the reaction is not a major obstacle. Interestingly, the anti-syn rotation of
trans-
[Pt(NH
3
)
2
(dG)Cl]
+
at position 7 is also possible. The yield of the reaction was too low to get an
estimate of the [tau]
1/2
at 37oC. However, this yield was increased up to 20% at 30oC and thus the dissociation of the triplex rather than a slow cross-linking reaction is the main reason for a low yield at 37oC. These results also suggest that both
trans-
[Pt(NH
3
)
2
(dG)Cl]
+
and
trans-
[Pt(NH
3
)
2
(dC)Cl]
+
) adducts should be able to form interstrand cross-links when the Hoogsteen strand is a platinated homopurine
oligonucleotide.
Can the yield and the rate of the cross-linking reaction be increased? It is clear that the monofunctional adducts
decrease the affinity of the Hoogsteen strand for the duplex and subsequently
decrease the yield of the reaction. Several papers have described ways to
increase the binding strength of the Hoogsteen strand (
25
-
27
and references therein) and we are currently investigating some of them. The
mechanism of the interstrand cross-linking reaction is still unknown. Two main pathways exist for the closure of the
monofunctional lesions into bifunctional lesions (
29
). One pathway is a direct nucleophilic attack of the G residue within the
purine-rich strand on the platinum residue. There are only few examples of such a
pathway in platinated nucleic acids (
19
,
21
,
22
,
28
). A major point of interest of this pathway is that in principle, the reaction
can complete in a few minutes. The more general pathway proceeds through solvent-associated intermediates and the rate-limiting step is hydrolysis of the chloride ion of the
monofunctional adduct (
17
,
20
,
29
). From the values of the [tau]
1/2
(monofunctional adducts in the triplexes) in the range 2-6 h, we cannot choose one of the two mechanisms. Whatever the mechanism,
assays for accelerating the cross-linking reactions are in progress by replacing transplatin by transplatin
derivatives with various leaving or non-leaving groups.
Concerning the anti-gene strategy, in addition to the suicide reaction of the free platinated
oligonucleotides, another problem specific to platinated oligonucleotides is
that the cells contain several compounds such as glutathione or proteins which
react strongly with platinum(II) complexes (
17
,
20
,
30
). We have verified that glutathione or thiourea react poorly with platinum(II) residues within the triplexes whereas they do react with the monofunctional adducts within the single-stranded oligonucleotides. Although several problems still exist, it seems possible that the platinated oligonucleotides could serve to improve the efficiency of the anti-gene oligonucleotides in modulation of gene expression and also as a
tool in molecular biology.
We are indebted to Dr M. Boudvillain and J. M. Malinge for helpful discussions.
This work was supported in part by la Ligue contre le Cancer, l'Association
pour la Recherche sur le Cancer, l'Agence Nationale de Recherche sur le Sida
and Deutsche Forschungsgemeinshaft.


REFERENCES
Return

